FREDERICK, Md., Jan. 22, 2018 /PRNewswire-PRWeb/ -- Nexus Discovery Advisors, LLC, is a newly formed consulting company
"During our decade-long careers at the National Institutes of Health, Dave and I were exposed to, and participated in exceptional scientific discoveries. Over time, we realized there was a need to help in the translation of these findings into small molecule therapeutics," said Dr. Matt Boxer, Managing Partner. "Our goal is to work closely with our clients to determine their needs and tailor a solution to rapidly and cost-effectively reach key inflection points and milestones," added Dr. Dave Maloney, Managing Partner.
Nexus Discovery Advisors will help clients in all aspects of preclinical drug discovery, whether they are looking to advance their drug discovery programs or need scientific diligence to assess in-licensing or investment opportunities. The company will maintain a foundation of collaborative and team-based science to rapidly move therapeutics towards the clinic and plans to continue helping build the biotechnology ecosystem in the area.
About Nexus Discovery Advisors: Nexus Discovery Advisors, LLC, located in Frederick MD, was founded with the passion to help biotechnology companies, investors, academia and government/non-profit organizations navigate all aspects of early stage drug discovery and preclinical work. Through detailed diligence, they provide innovative solutions, strategic planning and guidance from project inception to proof of concept and candidate selection. The advantage of Nexus Discovery Advisors is a team first philosophy that delivers an unwavering commitment and drive to achieve clients' objectives. For more information, please email us at info(at)NexusDA.com or visit our website, http://www.NexusDA.com.
SOURCE Nexus Discovery Advisors
Subscribe to our Free Newsletters!